Bruce T. Roberts, RPh—Mr. Roberts is executive vice president and chief executive officer of the National Community Pharmacists Association (NCPA).
Fall is here, and that means back to school and thinking about a future in independent pharmacy. Come consider all of your options at the NCPA 110th Annual Convention and Trade Exposition, October 11-15 in Tampa, Florida.
Choosing the path of independent pharmacy gives you the unique opportunity to develop exactly the type of pharmacy practice you want. For the past 5 years, one of the highlights of the Annual Convention has been the live Pruitt-Schutte Business Plan Competition. Teams from Samford University McWhorter School of Pharmacy, University of Arizona College of Pharmacy, and the University of Kansas will present their plans on how to buy an existing or develop a new community pharmacy. Since the inception of the competition, several participants have become successful owners, and it is a great way to kick-start the new school year and your own thoughts of pharmacy ownership.
Is now a good time to become an independent pharmacist? Today, more independent pharmacies are opening due to the demands of a growing and aging population. The pharmacy of the future is brimming with new technology, new concepts in delivering patient care, and innovative ways to launch your own practice that is both financially and professionally rewarding. And as always, there is the satisfaction of our customers.
A recent Consumer Reports article cites that readers rank independents with high scores for service, knowledge, products in stock, and customer satisfaction. So my answer is the answer I gave my own daughter who just graduated from pharmacy school: absolutely yes.
NCPA is pleased to partner with Pharmacy Careers, and we hope this issue piques your interest in independent pharmacy and NCPA. Visit us at www.ncpanet.org, or call us at 800-544-7447 to learn more.
In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine
Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.
News from the year's biggest meetings
Clinical features with downloadable PDFs